Fosfomycin in Osteomyelitis

Related Experiment Video

Updated: Oct 30, 2026

Combined In vivo Optical and µCT Imaging to Monitor Infection, Inflammation, and Bone Anatomy in an Orthopaedic Implant Infection in Mice
18:40

Combined In vivo Optical and µCT Imaging to Monitor Infection, Inflammation, and Bone Anatomy in an Orthopaedic Implant Infection in Mice

Published on: October 16, 2014

J E Fernandez-Valencia, T Saban, T Cañedo

    Chemotherapy
    |January 1, 1976
    PubMed

    Insights

    Fosfomycin effectively treated osteomyelitis in 37 patients, achieving a 78% cure rate. This antibiotic showed promise for bone infection management, even in patients not undergoing surgery.

    Area of Science:

    • Infectious Diseases
    • Orthopedic Surgery
    • Pharmacology

    Background:

    • Osteomyelitis is a challenging bone infection requiring effective treatment strategies.
    • Fosfomycin is a broad-spectrum antibiotic with potential utility in complex infections.

    Purpose of the Study:

    • To evaluate the efficacy of fosfomycin as a sole antibiotic treatment for osteomyelitis.
    • To assess treatment outcomes in patients with osteomyelitis, including those who underwent surgery and those who did not.

    Main Methods:

    • A cohort of 37 osteomyelitis patients received fosfomycin treatment.
    • Treatment involved parenteral and/or oral administration of fosfomycin at 4-8 g/day for approximately 3 weeks.
    • Patients were categorized based on surgical intervention (sequestrectomy/fistulectomy) or conservative management.

    Main Results:

    • A definitive cure rate of 78% (29 out of 37 patients) was achieved.
    • The study observed a 22% failure or relapse rate (8 out of 37 patients).
    • Outcomes were assessed after one or two treatment courses.

    Conclusions:

    • Fosfomycin demonstrates significant efficacy as an antibiotic treatment for osteomyelitis.
    • The antibiotic is effective in both surgically treated and non-surgically managed osteomyelitis patients.
    • Fosfomycin offers a viable therapeutic option for managing bone infections.

    More Related Videos

    Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection09:09

    Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection

    Published on: March 14, 2019

    A Periprosthetic Joint Candida albicans Infection Model in Mouse04:37

    A Periprosthetic Joint Candida albicans Infection Model in Mouse

    Published on: February 2, 2024

    Related Concept Videos

    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    Pulmonary Tuberculosis IV01:26

    Pulmonary Tuberculosis IV

    Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
    Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
    Acute Pyelonephritis I: Introduction01:27

    Acute Pyelonephritis I: Introduction

    Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...
    Acute Pyelonephritis II: Diagnostic Studies and Management01:28

    Acute Pyelonephritis II: Diagnostic Studies and Management

    Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...